NOCO Healthcare's Greeley Primary Care Redefines Community-Focused Medicine Women-Owned, Locally Operated Practice Earns Over 330 Five-Star Reviews While Expanding Patient-Centered Services GlobeNewswire January 31, 2026 Greeley, CO , Jan. 31, 2026 (GLOBE NEWSWIRE) — NOCO Healthcare is reshaping how patients experience medical care in Northern Colorado through its fast-growing Greeley Primary Care practice, known for […]

Capstone LLC, a leading policy analysis and investment research firm, has released its energy sector preview for 2026, identifying key policy and regulatory developments expected to impact mergers and acquisitions, agriculture, telecommunications infrastructure, and state and local government finances. Capstone expects the Trump administration to maintain a permissive stance on merger reviews, with most transactions

DUBAI, United Arab Emirates, Jan. 31, 2026 (GLOBE NEWSWIRE) — Building on the unprecedented success of its 2025 Masterclass, AEON Clinic, the Middle East's pioneer in regenerative wellness, proudly announces the Next Generation Medicine Congress 2026. This transformative four-day event will take place from 13th to 16th April 2026 at the iconic Atlantis The Palm,

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining the Future of Human Health GlobeNewswire January 31, 2026 DUBAI, United Arab Emirates, Jan. 31, 2026 (GLOBE NEWSWIRE) — Building on the unprecedented

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Blue Owl Capital Inc. ("Blue Owl" or the "Company") (NYSE:OWL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against SLM Corporation ("SLM" or the "Company") (NASDAQ:SLM) and certain officers.�� The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-18834 ,

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Coupang, Inc. ("Coupang" or the "Company") (NYSE:CPNG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ:FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / January 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Gauzy Ltd. ("Gauzy" or the "Company") (NASDAQ:GAUZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged